Idiopathic Pulmonary Fibrosis and Autoimmune Disease : Emerging
WebcastFaculty
OVERVIEW
Idiopathic Pulmonary Fibrosis and Autoimmune Disease : Emerging is organized by Cleveland Clinic Center for Continuing Education and would be held during May 30, 2017 - May 30, 2019.
The target audience for this medical event for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders. This CME Conference has been approved with a maximum of 0.25 AMA PRA Category 1 Credits.
Description :
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.
This webcast will review the histological features of idiopathic pulmonary fibrosis (IPF), as well as the lessons learned from anti-inflammatory, pulmonary vasculature, and multi-targeted trials.
Learning Objectives :
Review the non-inflammatory pathobiology of IPF.
Describe the multiple levels that are aberrant in IPF, including epithelial function, immune regulation, and fibrosis response.
Discuss the multi-target targeted therapy for IPF.
Additional details will be posted as soon as they are available.
The target audience for this medical event for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders. This CME Conference has been approved with a maximum of 0.25 AMA PRA Category 1 Credits.
Description :
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.
This webcast will review the histological features of idiopathic pulmonary fibrosis (IPF), as well as the lessons learned from anti-inflammatory, pulmonary vasculature, and multi-targeted trials.
Learning Objectives :
Review the non-inflammatory pathobiology of IPF.
Describe the multiple levels that are aberrant in IPF, including epithelial function, immune regulation, and fibrosis response.
Discuss the multi-target targeted therapy for IPF.
Additional details will be posted as soon as they are available.
SPECIALITIES
RheumatologyPulmonary Sciences and Critical CareImmunology and MicrobiologyRELATED ONLINE COURSES
Quick Links